Sign in to view content

Multicenter Randomized Sham-Controlled Double-Masked Phase 2b Clinical Trial of Multi-Characteristic Opsin in Patients With Advanced Retinitis Pigmentosa

Peter K. Kaiser, MD FASRS

Video
Published 2022

Related

Keynote Lecture: Developing New Retinal Theranostics by Integrating Engineering and Ophthalmology
Mark S. Humayun, MD, PhD
Updates from the Field
2018
Suprachoroidal Delivery of RGX-314 for Neovascular AMD: Initial Results From the Phase II AAVIATE Study
Mark R. Barakat, MD
Annual Meeting Talks
2021
Intravitreal Injection of Allogeneic Human Retinal Progenitor Cells for Treatment of Retinitis Pigmentosa: Results from the Phase 2b Trial
Anthony Joseph, MD
Annual Meeting Talks
2020

Category: Hereditary Retinal Disease & Genetics

See more